These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9591338)

  • 21. Molecular detection of dopamine decarboxylase expression by means of reverse transcriptase and polymerase chain reaction in bone marrow and peripheral blood: utility as a tumor marker for neuroblastoma.
    Bozzi F; Luksch R; Collini P; Gambirasio F; Barzanò E; Polastri D; Podda M; Brando B; Fossati-Bellani F
    Diagn Mol Pathol; 2004 Sep; 13(3):135-43. PubMed ID: 15322424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential detection of tumor cells in the peripheral blood and bone marrow of patients with stage IV neuroblastoma by the reverse transcription-polymerase chain reaction for tyrosine hydroxylase mRNA.
    Miyajima Y; Horibe K; Fukuda M; Matsumoto K; Numata S; Mori H; Kato K
    Cancer; 1996 Mar; 77(6):1214-9. PubMed ID: 8635146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of neuroblastoma cells in blood by reverse transcriptase-polymerase chain reaction.
    Gao Y; Li G; Zhang X; Xu Q; Zheng B
    Chin Med J (Engl); 1997 May; 110(5):341-5. PubMed ID: 9594298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Useful markers for detecting minimal residual disease in cases of neuroblastoma.
    Ootsuka S; Asami S; Sasaki T; Yoshida Y; Nemoto N; Shichino H; Chin M; Mugishima H; Suzuki T
    Biol Pharm Bull; 2008 Jun; 31(6):1071-4. PubMed ID: 18520032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma.
    Stutterheim J; Gerritsen A; Zappeij-Kannegieter L; Kleijn I; Dee R; Hooft L; van Noesel MM; Bierings M; Berthold F; Versteeg R; Caron HN; van der Schoot CE; Tytgat GA
    J Clin Oncol; 2008 Nov; 26(33):5443-9. PubMed ID: 18838715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of micrometastasis of neuroblastoma to bone marrow and tumor dissemination to hematopoietic autografts using flow cytometry and reverse transcriptase-polymerase chain reaction.
    Tsang KS; Li CK; Tsoi WC; Leung Y; Shing MM; Chik KW; Lee V; Ng MH; Yuen P
    Cancer; 2003 Jun; 97(11):2887-97. PubMed ID: 12767104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of protein gene product 9.5 and tyrosine hydroxylase in childhood small round cell tumors.
    Wang Y; Einhorn P; Triche TJ; Seeger RC; Reynolds CP
    Clin Cancer Res; 2000 Feb; 6(2):551-8. PubMed ID: 10690538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Supersensitive detection of tyrosine hydroxylase mRNA and neuroblastoma cells by reverse transcription and polymerase chain reaction].
    Naito H
    Hokkaido Igaku Zasshi; 1991 Mar; 66(2):135-41. PubMed ID: 1676393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of tyrosine hydroxylase mRNA for diagnosis and detection of minimal residual disease in neuroblastoma.
    Ito R; Asami S; Kagawa S; Motohashi S; Shichino H; Chin M; Yoshida Y; Nemoto N; Mugishima H; Suzuki T
    Biol Pharm Bull; 2004 Mar; 27(3):315-8. PubMed ID: 14993794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New splicing variants for human Tyrosine Hydroxylase gene with possible implications for the detection of minimal residual disease in patients with neuroblastoma.
    Parareda A; Villaescusa JC; Sanchez de Toledo J; Gallego S
    Neurosci Lett; 2003 Jan; 336(1):29-32. PubMed ID: 12493595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving Detection of Metastatic Neuroblastoma in Bone Marrow Core Biopsies: A Proposed Immunohistochemical Approach.
    Parsons LN; Gheorghe G; Yan K; Simpson P; Jarzembowski JA
    Pediatr Dev Pathol; 2016; 19(3):230-6. PubMed ID: 26491958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disseminated retinoblastoma successfully treated with myeloablative chemotherapy--implication for molecular detection of minimal residual disease.
    Yamane S; Shirai C; Arimoto A; Komura E; Ohmisono Y; Sawada T; Matsumura T
    Bone Marrow Transplant; 1999 May; 23(9):971-4. PubMed ID: 10338057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year.
    Burchill SA; Lewis IJ; Abrams KR; Riley R; Imeson J; Pearson AD; Pinkerton R; Selby P
    J Clin Oncol; 2001 Mar; 19(6):1795-801. PubMed ID: 11251011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow.
    Hoon DS; Kuo CT; Wen S; Wang H; Metelitsa L; Reynolds CP; Seeger RC
    Am J Pathol; 2001 Aug; 159(2):493-500. PubMed ID: 11485908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of tyrosine hydroxylase transcripts in bone marrow using biopsied tissue instead of aspirates for neuroblastoma.
    Lee ST; Suh YL; Ko YH; Ki CS; Sung KW; Kim HJ; Kim JW; Kim SH; Chueh H; Lee SH; Yoo KH; Koo HH
    Pediatr Blood Cancer; 2010 Aug; 55(2):273-8. PubMed ID: 20582938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective investigation of applicability and the prognostic significance of bone marrow involvement in patients with neuroblastoma detected by quantitative reverse transcription PCR.
    Druy AE; Shorikov EV; Tsaur GA; Popov AM; Zaychikov AN; Tuponogov SN; Saveliev LI; Tytgat GAM; Fechina LG
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27354. PubMed ID: 30007008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular detection of tyrosine hydroxylase in the peripheral blood of patients with neuroblastoma: useful at diagnosis but not predictive of subsequent relapse during off-therapy follow-up.
    Lee ST; Ki CS; Sung KW; Kim HJ; Kim JW; Kim SH; Lee SH; Yoo KH; Koo HH; Kim JY; Cho EJ
    Pediatr Hematol Oncol; 2011 Feb; 28(1):16-23. PubMed ID: 21083359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of microscopic disease: comparing histology, immunocytology, and RT-PCR of tyrosine hydroxylase, GAGE, and MAGE.
    Cheung IY; Cheung NK
    Med Pediatr Oncol; 2001 Jan; 36(1):210-2. PubMed ID: 11464887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic impact of the detection of microcirculating tumor cells by a real-time RT-PCR assay of tyrosine hydroxylase in patients with advanced neuroblastoma.
    Parareda A; Gallego S; Roma J; Llort A; Sábado C; Gros L; De Toledo JS
    Oncol Rep; 2005 Oct; 14(4):1021-7. PubMed ID: 16142367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA.
    Burchill SA; Bradbury FM; Smith B; Lewis IJ; Selby P
    Int J Cancer; 1994 Jun; 57(5):671-5. PubMed ID: 7910809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.